Experts explore the evolving landscape of chronic lymphocytic leukemia treatment, highlighting targeted therapies, MRD strategies, and future innovations.
Marc J. Braunstein, MD, PhD
Articles by Marc J. Braunstein, MD, PhD
Marc J. Braunstein, MD, PhD, discusses chimeric antigen receptor T-cell therapies, Bruton’s kinase inhibitors, and brentuximab vedotin that were highlighted at the 2020 Chemotherapy Foundation Symposium.
Marc J. Braunstein, MD, PhD, discusses the greatest challenge that still exists in the treatment paradigm of multiple myeloma.
Latest Updated Articles
Navigating the Future of CLL CarePublished: February 4th 2026 | Updated:
Challenges to Overcome in Treating Multiple MyelomaPublished: December 4th 2019 | Updated:
Therapies Discussed at CFS Show Responses for Hematologic MalignanciesPublished: November 4th 2020 | Updated: